Skip to main content

Rhodes Jason P's Form 4 filing

Generation Bio Co. (GBIO) · filed Sep 29, 2021

Accession no.
0001209191-21-058123
Filed
Sep 29, 2021
Trade date
Sep 27-29, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $2.06M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rhodes Jason PCIK 0001577014Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2021Common StockSSaleDisposed−51,294$25.70F2−$1,318,255.829,645Indirect
Sep 27, 2021Common StockSSaleDisposed−95$25.70F2−$2,441.5662Indirect
Sep 28, 2021Common StockSSaleDisposed−13,089$25.24F5−$330,366.3616,556Indirect
Sep 28, 2021Common StockSSaleDisposed−24$25.24F5−$605.76638Indirect
Sep 29, 2021Common StockSSaleDisposed−16,556$24.59F6−$407,112.040Indirect
Sep 29, 2021Common StockSSaleDisposed−30$24.59F6−$737.7608Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.07 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5) and (6).

Referenced by the price of 2 transactions in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.93 to $25.79 inclusive.

Referenced by the price of 2 transactions in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.46 to $25.36 inclusive.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)